RMC No. 156-2022: Updates to VAT-Exempt Medicines List for Common and Chronic Illnesses

RMC No. 156-2022 updates the VAT-exempt medicines list under the CREATE Act, covering chronic and life-threatening conditions. Businesses must adjust VAT calculations immediately. Businesses and healthcare providers must now adjust their VAT calculations immediately for certain medicines prescribed for hypertension, diabetes, high cholesterol, tuberculosis, mental illness, and cancer. The Food and Drug Administration’s latest update, […]

RMC No. 119-2022: VAT Exemption for Newly Endorsed COVID-19 Medicines

RMC No. 119-2022 adds Nirmatrelvir + Ritonavir 150 mg + 100 mg tablets for COVID-19 to the VAT-exempt list, effective from FDA publication, impacting healthcare providers and distributors. Businesses and healthcare providers must update their VAT-exempt inventory immediately: the Food and Drug Administration has added Nirmatrelvir + Ritonavir 150 mg + 100 mg film-coated tablets […]

RMC No. 112-2022: FDA-Endorsed Updates to VAT-Exempt Medicines Affecting Tuberculosis Treatments

RMC No. 112-2022 updates the VAT-exempt medicines list under the CREATE Act, adding tuberculosis medicines and removing COVID-19 medicines, affecting tax compliance for healthcare providers. Businesses in the pharmaceutical and healthcare sectors must immediately update their records and compliance processes due to the newly endorsed changes to the VAT-exempt medicines list. Certain medicines prescribed for […]

RMC No. 103-2021: Updated List of VAT-Exempt Medicines and COVID-19 Drugs for Immediate Compliance

RMC No. 103-2021 publishes updated VAT-exempt lists of medicines for hypertension, cancer, kidney diseases, and COVID-19 drugs, requiring immediate compliance for affected businesses. Businesses and taxpayers dealing with pharmaceutical products and COVID-19 treatments must immediately review the updated VAT-exempt lists published by the FDA and DOH. This update, under RMC No. 103-2021, supplements prior guidelines […]

Hospital Doctors Are Not Employees Just Because a Board Appointed Them

A hospital pathologist appointed by board resolution was not a corporate officer or employee because CDMC lacked by-law proof and work control. Professionals who serve a company may fall outside both corporate-officer status and employee status when their position is not fixed in the by-laws and the company does not control how, when, and where […]

RMC No. 4-2013: Tax-Exempt Hospitals Must Revalidate BIR Tax Exemption Rulings and Certificates

Tax-exempt hospitals with BIR rulings issued before November 1, 2012 must secure revalidated exemption certificates under RMC No. 4-2013. Tax-exempt hospitals and non-stock, non-profit entities operating hospitals must secure revalidated BIR tax exemption rulings or certificates if their previous exemptions were issued before November 1, 2012. Any prior ruling granting income tax exemption under Section […]

RR No. 12-98: Hospitals and Clinics Must Collect Doctors’ Professional Fees and Withhold Creditable Tax

RR No. 12-98 requires hospitals and clinics to collect doctors’ professional fees from admitted patients and withhold creditable tax, unless no fee is sworn. Hospitals and clinics must treat doctors’ professional fees as a withholding-tax compliance matter, not merely as a billing arrangement between the patient and the attending physician. RR No. 12-98 changes the […]